These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20459532)
21. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of Smac/DIABLO expression in colorectal cancer. Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
24. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641 [TBL] [Abstract][Full Text] [Related]
25. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262 [TBL] [Abstract][Full Text] [Related]
26. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication]. Yao HB; Wu AG; Chen YJ; Tang BH Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154 [TBL] [Abstract][Full Text] [Related]
27. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
28. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma]. He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709 [TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Li M; Li JY; Zhao AL; Gu J Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969 [TBL] [Abstract][Full Text] [Related]
32. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592 [TBL] [Abstract][Full Text] [Related]
33. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
34. Maspin expression and its clinical significance in non-small cell lung cancer. Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165 [TBL] [Abstract][Full Text] [Related]
35. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer. Huh JW; Kim HR; Kim YJ Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156 [TBL] [Abstract][Full Text] [Related]
37. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475 [TBL] [Abstract][Full Text] [Related]
38. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529 [TBL] [Abstract][Full Text] [Related]
39. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423 [TBL] [Abstract][Full Text] [Related]
40. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis]. Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]